NEW YORK (GenomeWeb News) – Metabolomics firm Metabolon and Spain's IMDEA Food today said they are collaborating on projects to develop functional foods and diagnostic tools.

The collaboration will focus on tools and food aimed at preventing prevalent chronic illnesses with high societal impact, such as cardiovascular disease, cancer, obesity, and neurological diseases, where in-depth studies characterizing the molecular underpinnings of the benefits of food and food components are needed, Metabolon and IMDEA Food said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.